Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Report of treatment intensity and survival outcomes in older patients with glioblastoma diagnosed according to WHO CNS 5 classification.

Journal of neuro-oncology·2026
Same author

Microglia-glioblastoma crosstalk mediates glioblastoma invasion at the far infiltration zone.

Immunity·2026
Same author

Microenvironmental TGF-β is an early driver of NF1-associated tumor formation.

Cell reports·2026
Same author

Understanding the difference in symptoms and outcomes between glioblastoma patients diagnosed based on histological or molecular criteria: a retrospective cohort analysis from the Histo-Mol GBM collaborative.

Journal of neuro-oncology·2026
Same author

Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication.

Biochemical pharmacology·2025
Same author

Axonal injury is a targetable driver of glioblastoma progression.

Nature·2025

Related Experiment Video

Updated: Aug 29, 2025

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.4K

Injury programs shape glioblastoma.

Lucy J Brooks1, Holly Simpson Ragdale1, Ciaran Scott Hill2

  • 1Samantha Dickson Brain Cancer Unit, Department of Cancer Biology, University College London Cancer Institute, London, UK.

Trends in Neurosciences
|September 11, 2022
PubMed
Summary
This summary is machine-generated.

Glioblastoma, an aggressive brain cancer, is resistant to therapy. Understanding its links to neurodevelopment and injury responses may offer new therapeutic strategies.

Keywords:
brain tumorcell type-specificdifferentiationinflammationmicroenvironmenttreatment resistance

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.0K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.0K

Related Experiment Videos

Last Updated: Aug 29, 2025

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.4K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.0K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.0K

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Developmental Neuroscience

Background:

  • Glioblastoma is a highly aggressive primary brain tumor with poor prognosis.
  • Therapeutic resistance remains a significant challenge in glioblastoma treatment.
  • Recent research reveals glioblastoma biology mirrors neurodevelopmental processes.
  • Cellular responses to injury play a role in tumor heterogeneity.

Purpose of the Study:

  • To review the impact of neurodevelopmental programs and injury responses on glioblastoma.
  • To explore how these biological processes influence tumor growth, invasion, and treatment resistance.
  • To discuss potential therapeutic avenues informed by these insights.

Main Methods:

  • Literature review and synthesis of current research.
  • Analysis of the interplay between glioblastoma cells and their microenvironment.
  • Examination of molecular and cellular mechanisms underlying tumor progression.

Main Results:

  • Glioblastoma tumors exhibit characteristics of neurodevelopmental hierarchies.
  • Injury response pathways significantly influence glioblastoma cell phenotypes and heterogeneity.
  • The interaction between developmental programs and injury responses drives tumor aggressiveness.
  • These biological underpinnings contribute to glioblastoma's resistance to therapies.

Conclusions:

  • Understanding the convergence of neurodevelopment and injury responses is crucial for glioblastoma research.
  • Targeting these fundamental biological processes may overcome therapeutic resistance.
  • New treatment strategies for glioblastoma could emerge from this integrated perspective.